Xponance, Inc. Abbott Laboratories Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Xponance, Inc. holds 242,460 shares of ABT stock, worth $27.2 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

242,460

Previous 239,511 1.23%

Holding current value

$27.2 Million

Previous $24.9 Million 11.07%

% of portfolio

0.27%

Previous 0.26%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $295,106 - $348,365	2,949 Added 1.23%	242,460 $27.6 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.12 Million - $1.25 Million	-11,115 Reduced 4.43%	239,511 $24.9 Million
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $1.61 Million - $1.78 Million	14,720 Added 6.24%	250,626 $28.5 Million
Q4 2023 Jan 31, 2024	BUY	$90.19 - $110.4 $1.61 Million - $1.97 Million	17,809 Added 8.17%	235,906 $26 Million
Q3 2023 Oct 23, 2023	BUY	$95.53 - $114.62 $353,652 - $424,323	3,702 Added 1.73%	218,097 $21.1 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $1.99 Million - $2.22 Million	-19,755 Reduced 8.44%	214,395 $23.4 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $164,758 - $193,931	-1,701 Reduced 0.72%	234,150 $23.7 Million
Q4 2022 Jan 23, 2023	BUY	$95.06 - $111.52 $3.21 Million - $3.77 Million	33,815 Added 16.74%	235,851 $0
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $2.45 Million - $2.83 Million	25,286 Added 14.31%	202,036 $19.5 Million
Q2 2022 Aug 02, 2022	SELL	$102.07 - $123.37 $5.66 Million - $6.84 Million	-55,417 Reduced 23.87%	176,750 $19.2 Million
Q1 2022 Apr 20, 2022	BUY	$114.02 - $139.04 $3.36 Million - $4.09 Million	29,433 Added 14.52%	232,167 $27.5 Million
Q4 2021 Jan 31, 2022	BUY	$115.53 - $141.46 $2.85 Million - $3.49 Million	24,648 Added 13.84%	202,734 $28.5 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $2.66 Million - $2.95 Million	-22,843 Reduced 11.37%	178,086 $21 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $689,433 - $811,562	-6,517 Reduced 3.14%	200,929 $23.3 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $74,881 - $88,222	-688 Reduced 0.33%	207,446 $24.9 Million
Q4 2020 Feb 11, 2021	BUY	$105.0 - $114.42 $224,175 - $244,286	2,135 Added 1.04%	208,134 $22.8 Million
Q3 2020 Oct 26, 2020	BUY	$91.64 - $111.29 $1.6 Million - $1.94 Million	17,459 Added 9.26%	205,999 $22.4 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $14.4 Million - $18.5 Million	188,540 New	188,540 $17.2 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account